ARTICLES BY THIS AUTHOR
- 6/26/2011
Low-tech solution to broaden access to medication history in B.C.
Manual system rolling out that will allow other healthcare providers to call the pharmacy to request the BPMH. - 6/26/2011
Safe sleep: preventing infant deaths
New joint statement provides evidence-based information to promote safe sleeping environments for infants and assist in preventing SIDS. - 6/26/2011
Reliable diagnostics a huge barrier to improving health across Africa
It’s estimated only 8% of all laboratories in sub-Saharan Africa meet international accreditation standards. An average rural lab in Africa serves anywhere from 5,000 to 15,000 people and most have poor infrastructure, insufficient staff and equipment shortages. Enter AMREF and its lab program, which provides technical assistance, disease outbreak investigations and research, as well as much-needed quality assessment. - 6/26/2011
OMA ‘blindsided’ by crackdown on fishy OHIP billing
TORONTO | The Ontario Medical Association is reeling from the provincial government’s decision to ramp up investigations into suspicious Ontario Health Insurance Plan (OHIP) billings—a decision that is sitting well with other health-care workers and groups. - 6/26/2011
London Drugs ransacked during Vancouver riot
A sad day for the city, says company’s president and CEO. - 6/26/2011
B.C. bans inducements on PharmaCare prescriptions
Pharmacies in B.C. may no longer use loyalty programs to encourage prescription orders. - 6/26/2011
Canada’s largest physician survey warns of chronic illness impact on the health care system
New data released June 27 from the 2010 National Physician Survey (NPS) shows that Canada’s doctors are finding it increasingly challenging to meet the changing health care needs of the ever growing number of Canadians living with chronic and complex medical conditions. - 6/23/2011
Adding bevacizumab to chemo improves ovarian cancer
CHICAGO | Two major ovarian cancer trials demonstrating the benefit of adding bevacizumab to traditional chemotherapy were presented at this year’s ASCO meeting. The first showed the angiogenesis blocker’s ability to extend progression-free survival in recurrent disease. The second suggested initial use of the tumour-starving drug for newly diagnosed cancer may be warranted, particularly in patients with more aggressive disease. - 6/23/2011
National EMR certification push ‘too little, too late’: critic
Canada Health Infoway defends new certification program